Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17081294)

  • 1. Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma.
    Taylor AC; Schuster K; McKenzie PP; Harris LC
    Mol Cancer; 2006 Nov; 5():53. PubMed ID: 17081294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX3 and PAX3-FKHR promote rhabdomyosarcoma cell survival through downregulation of PTEN.
    Li HG; Wang Q; Li HM; Kumar S; Parker C; Slevin M; Kumar P
    Cancer Lett; 2007 Aug; 253(2):215-23. PubMed ID: 17350164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
    Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
    Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene.
    Ayyanathan K; Fredericks WJ; Berking C; Herlyn M; Balakrishnan C; Gunther E; Rauscher FJ
    Cancer Res; 2000 Oct; 60(20):5803-14. PubMed ID: 11059777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.
    Sharma K; Patel YC; Srikant CB
    Mol Endocrinol; 1996 Dec; 10(12):1688-96. PubMed ID: 8961277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of AP-1 transcription activator induces myc-dependent apoptosis in HL60 cells.
    Park S; Hahm ER; Lee DK; Yang CH
    J Cell Biochem; 2004 Apr; 91(5):973-86. PubMed ID: 15034932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
    Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
    Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective sensitization to DNA-damaging agents in a human rhabdomyosarcoma cell line with inducible wild-type p53 overexpression.
    Gibson AA; Harwood FG; Tillman DM; Houghton JA
    Clin Cancer Res; 1998 Jan; 4(1):145-52. PubMed ID: 9516963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma.
    Wang W; Kumar P; Wang W; Epstein J; Helman L; Moore JV; Kumar S
    Cancer Res; 1998 Oct; 58(19):4426-33. PubMed ID: 9766674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc overexpression sensitizes Bim-mediated Bax activation for apoptosis induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through regulating Bcl-2/Bcl-xL expression.
    Jiang X; Tsang YH; Yu Q
    Int J Biochem Cell Biol; 2007; 39(5):1016-25. PubMed ID: 17331788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53.
    Sala A; Casella I; Grasso L; Bellon T; Reed JC; Miyashita T; Peschle C
    Cancer Res; 1996 May; 56(9):1991-6. PubMed ID: 8616838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy.
    Tonelli R; McIntyre A; Camerin C; Walters ZS; Di Leo K; Selfe J; Purgato S; Missiaglia E; Tortori A; Renshaw J; Astolfi A; Taylor KR; Serravalle S; Bishop R; Nanni C; Valentijn LJ; Faccini A; Leuschner I; Formica S; Reis-Filho JS; Ambrosini V; Thway K; Franzoni M; Summersgill B; Marchelli R; Hrelia P; Cantelli-Forti G; Fanti S; Corradini R; Pession A; Shipley J
    Clin Cancer Res; 2012 Feb; 18(3):796-807. PubMed ID: 22065083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
    Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL
    Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin gallate induced apoptosis in Sarcoma180 cells in vivo: mediated by p53 pathway and inhibition in U1B, U4-U6 UsnRNAs expression.
    Manna S; Banerjee S; Mukherjee S; Das S; Panda CK
    Apoptosis; 2006 Dec; 11(12):2267-76. PubMed ID: 17041754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein.
    Xia SJ; Barr FG
    Oncogene; 2004 Sep; 23(41):6864-71. PubMed ID: 15286710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR.
    Margue CM; Bernasconi M; Barr FG; Schäfer BW
    Oncogene; 2000 Jun; 19(25):2921-9. PubMed ID: 10871843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells.
    Jiang MC; Yang-Yen HF; Lin JK; Yen JJ
    Oncogene; 1996 Aug; 13(3):609-16. PubMed ID: 8760302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma.
    Anderson J; Ramsay A; Gould S; Pritchard-Jones K
    Am J Pathol; 2001 Sep; 159(3):1089-96. PubMed ID: 11549601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 and c-Myc, but not bax and p53, are expressed during human medullary thyroid tumorigenesis.
    Wang DG; Liu WH; Johnston CF; Sloan JM; Buchanan KD
    Am J Pathol; 1998 Jun; 152(6):1407-13. PubMed ID: 9626044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.